Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue

摘要

Pharmaceutical combination compositions including as a first compound estrogen agonists/antagonists and as a second compound sodium fluoride, a parathyroid hormone or growth hormone. The compositions are useful for the treatment of bone disorders including osteoporosis.